Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Mol Syst Biol ; 13(5): 928, 2017 05 03.
Artigo em Inglês | MEDLINE | ID: mdl-28468958

RESUMO

The RAF-MEK-ERK signalling pathway controls fundamental, often opposing cellular processes such as proliferation and apoptosis. Signal duration has been identified to play a decisive role in these cell fate decisions. However, it remains unclear how the different early and late responding gene expression modules can discriminate short and long signals. We obtained both protein phosphorylation and gene expression time course data from HEK293 cells carrying an inducible construct of the proto-oncogene RAF By mathematical modelling, we identified a new gene expression module of immediate-late genes (ILGs) distinct in gene expression dynamics and function. We find that mRNA longevity enables these ILGs to respond late and thus translate ERK signal duration into response amplitude. Despite their late response, their GC-rich promoter structure suggested and metabolic labelling with 4SU confirmed that transcription of ILGs is induced immediately. A comparative analysis shows that the principle of duration decoding is conserved in PC12 cells and MCF7 cells, two paradigm cell systems for ERK signal duration. Altogether, our findings suggest that ILGs function as a gene expression module to decode ERK signal duration.


Assuntos
Regulação da Expressão Gênica , Sistema de Sinalização das MAP Quinases/genética , RNA Mensageiro/metabolismo , Animais , Simulação por Computador , Sequência Rica em GC , Células HEK293 , Meia-Vida , Humanos , Células MCF-7 , Modelos Teóricos , Família Multigênica , Células PC12 , Regiões Promotoras Genéticas , Proto-Oncogene Mas , Ratos , Transdução de Sinais/genética , Quinases raf/genética
2.
Eur J Immunol ; 44(9): 2822-34, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24895051

RESUMO

Haploidentical stem cell transplantation (haploSCT) offers an alternative treatment option for advanced leukemia patients lacking a HLA-compatible donor. Transfer of NK cells represents a promising therapeutic option in combination with SCT, as NK cells can promote graft versus leukemia with low risk of GVH disease. In this study, we show results from a phase I/II trial in which 24 acute myeloid leukemia patients underwent haploSCT in combination with early transfer of unmodified NK cells and observed a promising 2-year overall survival rate of 37%. By performing immunomonitoring and subsequent principal component analysis, we tracked donor NK-cell dynamics in the patients and distinguished between NK cells reconstituting from CD34(+) precursors, giving rise over time to a continuum of multiple differentiation stages, and adoptively transferred NK cells. Transferred NK cells displayed a mature phenotype and proliferated in vivo during the early days after haploSCT even in the absence of exogenous IL-2 administration. Moreover, we identified the NK-cell phenotype associated with in vivo expansion. Thus, our study indicates a promising path for adoptive transfer of unmodified NK cells in the treatment of high-risk acute myeloid leukemia.


Assuntos
Células Matadoras Naturais/imunologia , Leucemia Mieloide Aguda , Transplante de Células-Tronco , Doadores não Relacionados , Adulto , Antineoplásicos/farmacologia , Proliferação de Células/efeitos dos fármacos , Intervalo Livre de Doença , Feminino , Seguimentos , Humanos , Interleucina-2/farmacologia , Células Matadoras Naturais/patologia , Leucemia Mieloide Aguda/imunologia , Leucemia Mieloide Aguda/mortalidade , Leucemia Mieloide Aguda/terapia , Masculino , Pessoa de Meia-Idade , Fenótipo , Fatores de Risco , Taxa de Sobrevida
3.
Immunity ; 38(6): 1223-35, 2013 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-23791642

RESUMO

RORγt⁺ innate lymphoid cells (ILCs) are crucial players of innate immune responses and represent a major source of interleukin-22 (IL-22), which has an important role in mucosal homeostasis. The signals required by RORγt⁺ ILCs to express IL-22 and other cytokines have been elucidated only partially. Here we showed that RORγt⁺ ILCs can directly sense the environment by the engagement of the activating receptor NKp44. NKp44 triggering in RORγt⁺ ILCs selectively activated a coordinated proinflammatory program, including tumor necrosis factor (TNF), whereas cytokine stimulation preferentially induced IL-22 expression. However, combined engagement of NKp44 and cytokine receptors resulted in a strong synergistic effect. These data support the concept that NKp44⁺ RORγt⁺ ILCs can be activated without cytokines and are able to switch between IL-22 or TNF production, depending on the triggering stimulus.


Assuntos
Interleucinas/metabolismo , Linfócitos/imunologia , Receptor 2 Desencadeador da Citotoxicidade Natural/metabolismo , Células Cultivadas , Microambiente Celular , Homeostase , Humanos , Imunidade Inata , Mediadores da Inflamação/metabolismo , Mucosa/imunologia , Receptor 2 Desencadeador da Citotoxicidade Natural/imunologia , Membro 3 do Grupo F da Subfamília 1 de Receptores Nucleares/metabolismo , Tonsila Palatina/citologia , Tonsila Palatina/imunologia , Receptor Cross-Talk , Transdução de Sinais , Fator de Necrose Tumoral alfa/metabolismo , Interleucina 22
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA